Insidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamI won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022We haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearMino-WrapAn actualiMSCupdateThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Hemorrhoidsis a $2BmarketNot manycompaniesthis size with2 late stageassetsMyron Holubiakand I founded aprivatecompany in2013There are noFDAapproveddrugs to treathemorrhoidsI/ONTAKis our leadassetMino-Lokpotentialmarket>$1BWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfI/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacyMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022We willhaveexclusivityInsidersinvested$26.5mOnly biotechwith 2 Myron'son theleadershipteamI won't diluteshareholdersOur Halo-Lido trial willhave finalpatient byend of 2022We haveenough cashto go wellinto 2023I/ONTAK waspreviouslyapproved buttaken off themarket to improvemanufacturing.We expect tofinish theMino-Loktrial this yearMino-WrapAn actualiMSCupdateThe name Citiuscomes from theOlympic motto"Citius,AltiusFortius"Hemorrhoidsis a $2BmarketNot manycompaniesthis size with2 late stageassetsMyron Holubiakand I founded aprivatecompany in2013There are noFDAapproveddrugs to treathemorrhoidsI/ONTAKis our leadassetMino-Lokpotentialmarket>$1BWe will openupinternationalsites forMino-Lok trialI'm ashareholdermyselfI/ONTAK'spotentialmarket is>$300mWe had aphase 2btrial with100%efficacyMino-Lokis our leadassetI/ONTAKwas thebest deal Iever madeWe intendto submita BLA in2H 2022We willhaveexclusivity

Leonard Mazur HCW Conference - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
  1. Insiders invested $26.5m
  2. Only biotech with 2 Myron's on the leadership team
  3. I won't dilute shareholders
  4. Our Halo-Lido trial will have final patient by end of 2022
  5. We have enough cash to go well into 2023
  6. I/ONTAK was previously approved but taken off the market to improve manufacturing.
  7. We expect to finish the Mino-Lok trial this year
  8. Mino-Wrap
  9. An actual iMSC update
  10. The name Citius comes from the Olympic motto "Citius,Altius Fortius"
  11. Hemorrhoids is a $2B market
  12. Not many companies this size with 2 late stage assets
  13. Myron Holubiak and I founded a private company in 2013
  14. There are no FDA approved drugs to treat hemorrhoids
  15. I/ONTAK is our lead asset
  16. Mino-Lok potential market >$1B
  17. We will open up international sites for Mino-Lok trial
  18. I'm a shareholder myself
  19. I/ONTAK's potential market is >$300m
  20. We had a phase 2b trial with 100% efficacy
  21. Mino-Lok is our lead asset
  22. I/ONTAK was the best deal I ever made
  23. We intend to submit a BLA in 2H 2022
  24. We will have exclusivity